These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16197308)

  • 1. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women.
    Herrmann M; Kraenzlin M; Pape G; Sand-Hill M; Herrmann W
    Clin Chem Lab Med; 2005; 43(10):1118-23. PubMed ID: 16197308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of parity and homocysteine to bone mineral density of postmenopausal women.
    Yilmaz N; Kepkep N; Ciçek HK; Celik A; Meram I
    Clin Lab; 2006; 52(1-2):49-56. PubMed ID: 16506364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
    Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
    Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women.
    Bahtiri E; Islami H; Rexhepi S; Qorraj-Bytyqi H; Thaçi K; Thaçi S; Karakulak C; Hoxha R
    Acta Reumatol Port; 2015; 40(4):355-62. PubMed ID: 26922199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial.
    Herrmann M; Umanskaya N; Traber L; Schmidt-Gayk H; Menke W; Lanzer G; Lenhart M; Peter Schmidt J; Herrmann W
    Clin Chem Lab Med; 2007; 45(12):1785-92. PubMed ID: 18020969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
    Krupa B
    Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people.
    Dhonukshe-Rutten RA; Pluijm SM; de Groot LC; Lips P; Smit JH; van Staveren WA
    J Bone Miner Res; 2005 Jun; 20(6):921-9. PubMed ID: 15883631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.
    Nava-Valdivia CA; Ponce-Guarneros JM; Saldaña-Cruz AM; Corona-Sanchez EG; Ramirez-Villafaña M; Perez-Guerrero EE; Murillo-Saich JD; Contreras-Haro B; Vazquez-Villegas ML; Gonzalez-Ponce F; Bonilla-Lara D; Jacobo-Cuevas H; Centeno-Valadez JD; Echeverria-Gonzalez G; Cerpa-Cruz S; Alcaraz-Lopez MF; Cardona-Muñoz EG; Salazar-Paramo M; Gonzalez-Lopez L; Gamez-Nava JI
    Biomed Res Int; 2021; 2021():5567666. PubMed ID: 34497849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women.
    Gerdhem P; Ivaska KK; Isaksson A; Pettersson K; Väänänen HK; Obrant KJ; Akesson K
    J Bone Miner Res; 2007 Jan; 22(1):127-34. PubMed ID: 17032146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis.
    Yilmaz N; Eren E
    Aging Clin Exp Res; 2009; 21(4-5):353-7. PubMed ID: 19959926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.
    Oelzner P; Franke S; Lehmann G; Eidner T; Müller A; Wolf G; Hein G
    Clin Rheumatol; 2007 Dec; 26(12):2127-2135. PubMed ID: 17541498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women.
    Markatseli AE; Hatzi E; Bouba I; Georgiou I; Challa A; Tigas S; Tsatsoulis A
    Maturitas; 2011 Oct; 70(2):188-93. PubMed ID: 21840657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women.
    Haliloglu B; Aksungar FB; Ilter E; Peker H; Akin FT; Mutlu N; Ozekici U
    Arch Gynecol Obstet; 2010 Apr; 281(4):663-8. PubMed ID: 19946695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period?
    Chung KW; Kim MR; Yoo SW; Kwon DJ; Lim YT; Kim JH; Lee JW
    Arch Gynecol Obstet; 2000 Nov; 264(3):119-23. PubMed ID: 11129509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients.
    Zhu Y; Shen J; Cheng Q; Fan Y; Lin W
    Clin Interv Aging; 2016; 11():1117-21. PubMed ID: 27574411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
    Jiang LS; Zhang ZM; Jiang SD; Chen WH; Dai LY
    J Bone Miner Res; 2008 Apr; 23(4):475-83. PubMed ID: 18052758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
    Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
    J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.